The Impact of Fewer Hip Fractures with Risedronate Versus Alendronate in the First Year of Treatment: Modeled German Cost-Effectiveness Analysis
Autor: | Thompson, Melissa, Pasquale, Margaret, Grima, Daniel, Moehrke, Werner, Kruse, Hans Peter |
---|---|
Zdroj: | In Value in Health 2010 13(1):46-54 |
Databáze: | ScienceDirect |
Externí odkaz: |